European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Care Payment Schemes by Country

In 2023, France led European countries in voluntary healthcare payment schemes for pharmaceuticals, with 1.54 billion euros, despite an 8.3% decline from the previous year. Switzerland, Slovenia, and Germany followed, exhibiting declines and modest growth. Notably, Malta, Lithuania, and Latvia showed significant growth rates of 20%, 14.51%, and 34.26% respectively. Luxembourg and Estonia also demonstrated notable increases. Conversely, countries such as Liechtenstein, Cyprus, and France faced declines in their expenditures.

Future trends to watch include:

• Shift towards innovative healthcare funding models.
• Impact of economic fluctuations on voluntary payment capacities.
• Increasing role of preventive healthcare affecting expenditure focus.
• Potential regulatory and policy changes across Europe influencing expenditure trends.